Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy

Background: Gonadotropin-releasing hormone agonists (GnRHa), used in the treatment of prostate cancer (PC) and for reproductive purposes in women, have been implicated as the cause of pituitary apoplexy (PA), a potentially life-threatening condition. The pathophysiology of PA after GnRHa has not bee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Yu, Xiaoling, Guarda, Francisco J, Shiraliyeva, Naila, Haines, Melanie S, Saylor, Philip J, Nachtigall, Lisa B
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Neuroendocrinology and Pituitary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090722/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1281
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados